R Bassan, E Pogliani, T Lerede, P Fabris, G Rossi, S Morandi, P Casula, G Lambertenghi-Deliliers, M Vespignani, T Izzi, P Coser, G Corneo, and T Barbui. 1999. “Fractionated Cyclophosphamide Added to the IVAP Regimen (idarubicin-Vincristine-L-Asparaginase-Prednisone) Could Lower the Risk of Primary Refractory Disease in T-Lineage But Not B-Lineage Acute Lymphoblastic Leukemia: First Results from a Phase II Clinical Study”. Haematologica 84 (12). Pavia, Italy, 1088-93. https://doi.org/10.3324/%x.